What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 5 minute read Pharma Industry News Unicycive (NASDAQ: UNCY) hit by FDA manufacturing concerns ahead of oxylanthanum carbonate decision Unicycive’s NDA for oxylanthanum carbonate faces FDA manufacturing concerns. Key decision expected June 28. Read the stock outlook and next steps. byPallavi MadhirajuJune 10, 2025